A combination of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) appears promising for locally advanced and metastatic pancreatic cancer

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1582-1583, 2007-01, pp. : 8-8

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Multicenter, randomized phase II trial of bevacizumab plus folinic acid, fluorouracil, gemcitabine (FFG) versus bevacizumab plus folinic acid, fluorouracil, oxaliplatin (FOLFOX4) as first-line therapy for patients with advanced colorectal cancer

By Madajewicz Stefan  

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 772-778

Springer Publishing Company

Access to resources Recommend Favorite

Weekly Gemcitabine plus Fluorouracil-Folinic Acid Given Weekly for Two Days in Patients with Advanced Pancreatic Cancer: A Phase II Study

By Aristides Polyzos  

Clinical Drug Investigation, Vol. 24, Iss. 11, 2004-01 ,pp. : 661-670

Adis International

Access to resources Recommend Favorite

Oxaliplatin: A Review of its Use in Combination Therapy for Advanced Metastatic Colorectal Cancer

By Simpson D.   Dunn C.   Curran M.   Goa K.L.  

Drugs, Vol. 63, Iss. 19, 2003-01 ,pp. : 2127-2156

Adis International

Access to resources Recommend Favorite

Fluorouracil/folinic acid/oxaliplatin: Fatal pulmonary fibrosis: case report

By  

Reactions Weekly, Vol. 1, Iss. 1207, 2008-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Fluorouracil/folinic acid/oxaliplatin: Delayed onset nausea and vomiting: case report

By  

Reactions Weekly, Vol. 1, Iss. 1318, 2010-01 ,pp. : 22-22

Adis International

Access to resources Recommend Favorite